Skip to main content
. Author manuscript; available in PMC: 2017 Apr 4.
Published in final edited form as: Value Health. 2017 Jan 10;20(1):2–14. doi: 10.1016/j.jval.2016.11.005

Fig. 1.

Fig. 1

Direct to indirect assessments of treatment benefit. ADAS-COG, Alzheimer’s Disease Assessment Scale—Cognitive; ALS, amyotrophic lateral sclerosis; BPRS, Brief Psychiatric Rating Scale; COA, clinical outcome assessment; CT, computed tomography; ETDRS, Early Treatment Diabetic Retinopathy Study; EXACT-PRO, the EXAcerbaCTtions of chronic pulmonary disease tool; FVC, forced vital capacity; FEV1, forced expiratory volume in 1; FLU-PRO, InFLUenza Patient-Reported Outcome; HgbA1c, glycated hemoglobin; HIV, human immunodeficiency virus; MRI, magnetic resonance imaging; SDMT, Symbol Digit Modalities Test.